VVP
ANGO icon

Venture Visionary Partners’s AngioDynamics ANGO Stock Holding History

Venture Visionary Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-400
Closed -$7.74K – 511
2022
Q2 		$7.74K Buy
+400
New +$8.19K ﹤0.01% 1309

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Venture Visionary Partners's ANGO Position: Q3 2022 in Review

Venture Visionary Partners sold out of AngioDynamics (ANGO) in Q3 2022, closing a stake of 400 shares — an estimated $7.74K sold.

Venture Visionary Partners first reported a position in ANGO in Q2 2022 and held it in 1 quarter. The position peaked at $7.74K in Q2 2022. 149 funds tracked by Wall St. Rank hold ANGO as of Q3 2022.

  • Venture Visionary Partners reported no remaining AngioDynamics position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 400 AngioDynamics shares in Q3 2022, an estimated $7.74K.
  • Venture Visionary Partners first reported a position in AngioDynamics in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's AngioDynamics position peaked at $7.74K in Q2 2022.
  • 149 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.